Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (307) 307
life sciences & biomedicine (293) 293
humans (271) 271
neurosciences & neurology (233) 233
female (216) 216
male (216) 216
magnetic resonance imaging (203) 203
clinical neurology (185) 185
neurology (165) 165
middle aged (162) 162
neurosciences (136) 136
aged (128) 128
adult (110) 110
multiple sclerosis (95) 95
biological and medical sciences (93) 93
medical sciences (93) 93
brain - pathology (91) 91
alzheimer's disease (84) 84
neuroimaging (84) 84
magnetic resonance imaging - methods (81) 81
abridged index medicus (67) 67
aged, 80 and over (67) 67
radiology, nuclear medicine & medical imaging (66) 66
atrophy (60) 60
brain (58) 58
dementia (54) 54
mri (49) 49
multiple sclerosis - pathology (49) 49
neuropsychological tests (49) 49
cognition (43) 43
disease progression (42) 42
nervous system (42) 42
alzheimer disease - pathology (39) 39
patients (39) 39
cognitive ability (36) 36
diagnosis (36) 36
nuclear magnetic resonance--nmr (36) 36
biomarkers (32) 32
brain - diagnostic imaging (32) 32
medical research (32) 32
memory (32) 32
multiple sclerosis - diagnosis (32) 32
follow-up studies (31) 31
research (31) 31
brain mapping (30) 30
degenerative and inherited degenerative diseases of the nervous system. leukodystrophies. prion diseases (30) 30
image processing, computer-assisted (30) 30
medicin och hälsovetenskap (30) 30
studies (30) 30
psychiatry (29) 29
analysis (28) 28
brain research (27) 27
pathology (27) 27
risk factors (27) 27
alzheimer disease - diagnosis (26) 26
longitudinal studies (26) 26
usage (26) 26
medicine, experimental (25) 25
multiple sclerosis and variants. guillain barré syndrome and other inflammatory polyneuropathies. leukoencephalitis (25) 25
young adult (25) 25
alzheimers disease (24) 24
cardiovascular system & cardiology (24) 24
internal medicine (24) 24
multiple sclerosis - physiopathology (24) 24
case-control studies (23) 23
clinical trials (23) 23
predictive value of tests (23) 23
sensitivity and specificity (23) 23
alzheimer’s disease (22) 22
brain - physiopathology (22) 22
investigative techniques, diagnostic techniques (22) 22
medicine & public health (22) 22
peripheral vascular disease (22) 22
b_open_article_in_toll_access_journal (21) 21
mild cognitive impairment (21) 21
psychiatry and mental health (21) 21
alzheimer disease - physiopathology (20) 20
care and treatment (20) 20
medical imaging (20) 20
multiple sclerosis - diagnostic imaging (20) 20
neuroscience (20) 20
prospective studies (20) 20
severity of illness index (20) 20
adolescent (19) 19
cerebral cortex - pathology (19) 19
cognition disorders - pathology (19) 19
geriatrics & gerontology (19) 19
organ size (19) 19
radiology nuclear medicine and imaging (19) 19
aging (18) 18
alzheimer disease (18) 18
clinical medicine (18) 18
cohort studies (18) 18
cross-sectional studies (18) 18
disability evaluation (18) 18
neuroradiology (18) 18
radiodiagnosis. nmr imagery. nmr spectrometry (18) 18
vascular diseases and vascular malformations of the nervous system (18) 18
algorithms (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
by Dodel, Richard, Prof and Rominger, Axel, MD and Bartenstein, Peter, MD and Barkhof, Frederik, MD and Blennow, Kaj, PhD and Förster, Stefan, MD and Winter, Yaroslav, MD and Bach, Jan-Philipp, MD and Popp, Julius, MD and Alferink, Judith, MD and Wiltfang, Jens, MD and Buerger, Katharina, MD and Otto, Markus, MD and Antuono, Piero, MD and Jacoby, Michael, MD and Richter, Ralph, MD and Stevens, James, MD and Melamed, Isaac, MD and Goldstein, Jerome, MD and Haag, Stefan, MD and Wietek, Stefan, PhD and Farlow, Martin, MD and Jessen, Frank, MD and Sahlgrenska akademin and Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi and Göteborgs universitet and Gothenburg University and Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry and Sahlgrenska Academy
Lancet neurology, ISSN 1474-4422, 2013, Volume 12, Issue 3, pp. 233 - 243
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Severity of Illness Index | Double-Blind Method | Area Under Curve | Humans | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Alzheimer Disease - drug therapy | Immunoglobulins, Intravenous - administration & dosage | Male | Amyloid beta-Peptides - blood | Alzheimer Disease - diagnosis | Dose-Response Relationship, Drug | Aged, 80 and over | Placebos | Female | Aged | Alzheimer Disease - immunology | Immunoglobulins, Intravenous - blood | Medical colleges | Immunoglobulins | Care and treatment | Neurosciences | Image processing | Analysis | Amyloid beta-protein | Clinical trials | Equipment and supplies | Alzheimer's disease | Index Medicus | Stroke | Intravenous administration | Neurodegenerative diseases | biomarkers | Cognitive ability | beta -Amyloid | Positron emission tomography | Drug | drug therapy | Intravenous | diagnosis | Alzheimer Disease | blood | 80 and over | administration & dosage | Amyloid beta-Peptides | adverse effects | Dose-Response Relationship | immunology | Neurovetenskaper
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
by Wardlaw, Joanna M, Prof and Smith, Eric E, MD and Biessels, Geert J, MD and Cordonnier, Charlotte, Prof and Fazekas, Franz, Prof and Frayne, Richard, Prof and Lindley, Richard I, Prof and O'Brien, John T, Prof and Barkhof, Frederik, Prof and Benavente, Oscar R, Prof and Black, Sandra E, MD and Brayne, Carol, Prof and Breteler, Monique, Prof and Chabriat, Hugues, Prof and DeCarli, Charles, Prof and de Leeuw, Frank-Erik, MD and Doubal, Fergus, PhD and Duering, Marco, MD and Fox, Nick C, Prof and Greenberg, Steven, Prof and Hachinski, Vladimir, Prof and Kilimann, Ingo, MD and Mok, Vincent, Prof and Oostenbrugge, Robert van, Prof and Pantoni, Leonardo, MD and Speck, Oliver, Prof and Stephan, Blossom C M, PhD and Teipel, Stefan, Prof and Viswanathan, Anand, MD and Werring, David, PhD and Chen, Christopher, MD and Smith, Colin, MD and van Buchem, Mark, Prof and Norrving, Bo, Prof and Gorelick, Philip B, MD and Dichgans, Martin, Prof and STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1) and STand Reporting Vasc Changes
Lancet neurology, ISSN 1474-4422, 2013, Volume 12, Issue 8, pp. 822 - 838
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neuroimaging - methods | Guidelines as Topic | Humans | Cerebral Small Vessel Diseases - classification | Neurodegenerative Diseases - diagnosis | Terminology as Topic | Male | International Cooperation | Cerebral Small Vessel Diseases - complications | Neuroimaging - classification | Cerebral Small Vessel Diseases - diagnosis | Image Processing, Computer-Assisted | Aging | Female | Neuroimaging - standards | Medicine, Experimental | Medical research | Diagnostic imaging | Index Medicus | Position Paper | Neurologi | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
by Kappos, Ludwig, Prof and Li, David, MD and Calabresi, Peter A, MD and O'Connor, Paul, MD and Bar-Or, Amit, MD and Barkhof, Frederik, Prof and Yin, Ming, PhD and Leppert, David, MD and Glanzman, Robert, MD and Tinbergen, Jeroen, MD and Hauser, Stephen L, Prof
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9805, pp. 1779 - 1787
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Biological and medical sciences | General aspects | Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis | Medical sciences | Interferon-beta - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Multiple Sclerosis, Relapsing-Remitting - immunology | Double-Blind Method | Drug Administration Schedule | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Gadolinium | Male | Multiple Sclerosis, Relapsing-Remitting - diagnosis | B-Lymphocytes - drug effects | Magnetic Resonance Imaging | Antibodies, Monoclonal, Humanized - administration & dosage | Contrast Media | Interferon-beta - adverse effects | Brain - pathology | Adult | Female | Infusions, Intravenous | Multiple sclerosis | Monoclonal antibodies | Physiological aspects | Research | Diagnosis | B cells | Drug therapy | Health aspects | Data collection | Medical research | Cytotoxicity | Clinical medicine | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm
by Cole PhD, James H and Raffel MD, Joel and Friede PhD, Tim and Eshaghi MD, PhD, Arman and Brownlee PhD, FRACP, Wallace J and Chard MD, PhD, Declan and De Stefano MD, PhD, Nicola and Enzinger MD, Christian and Pirpamer MSc, Lukas and Filippi MD, FEAN, Massimo and Gasperini MD, Claudio and Rocca MD, Maria Assunta and Rovira MD, Alex and Ruggieri MD, Serena and Sastre-Garriga MD, PhD, Jaume and Stromillo MD, PhD, Maria Laura and Uitdehaag MD, PhD, Bernard M.J and Vrenken PhD, Hugo and Barkhof MD PhD, Frederik and Nicholas MD, PhD, Richard and Ciccarelli PhD, FRCP, Olga and MAGNIMS Study Grp and MAGNIMS study group
Annals of neurology, ISSN 0364-5134, 07/2020, Volume 88, Issue 1, pp. 93 - 105
Neurology | Clinical Neurology | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Confidence intervals | Atrophy | Neuroimaging | Brain | Multiple sclerosis | Magnetic resonance imaging | Aging | Biomarkers | Aging (natural) | Disease control | Age | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
by Filippi, Massimo, Prof and Rocca, Maria A, MD and Ciccarelli, Olga, Prof and De Stefano, Nicola, MD and Evangelou, Nikos, PhD and Kappos, Ludwig, Prof and Rovira, Alex, MD and Sastre-Garriga, Jaume, MD and Tintorè, Mar, MD and Frederiksen, Jette L, Prof and Gasperini, Claudio, MD and Palace, Jacqueline, MD and Reich, Daniel S, MD and Banwell, Brenda, Prof and Montalban, Xavier, Prof and Barkhof, Frederik, Prof and MAGNIMS Study Group and MAGNIMS Study Grp
Lancet neurology, ISSN 1474-4422, 2016, Volume 15, Issue 3, pp. 292 - 303
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Magnetic Resonance Imaging - methods | Multiple Sclerosis - diagnosis | Humans | Consensus | Practice Guidelines as Topic | Multiple sclerosis | Neurosciences | Diagnostic imaging | Diagnosis | Research institutes | Studies | Spinal cord | Funding | Compensation | Clinical trials | Pharmaceutical industry | Revisions | Index Medicus | Multiple Sclerosis | Magnetic Resonance Imaging | Criteria
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial
by Kappos, Ludwig, MD and Freedman, Mark S, MD and Polman, Chris H, MD and Edan, Gilles, MD and Hartung, Hans-Peter, MD and Miller, David H, MD and Montalbán, Xavier, MD and Barkhof, Frederik, MD and Radü, Ernst-Wilhelm, MD and Metzig, Carola, MD and Bauer, Lars, MD and Lanius, Vivian, PhD and Sandbrink, Rupert, MD and Pohl, Christoph, MD and for the BENEFIT Study Group and BENEFIT Study Grp and BENEFIT Study Group
Lancet neurology, ISSN 1474-4422, 2009, Volume 8, Issue 11, pp. 987 - 997
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Disability Evaluation | Data Interpretation, Statistical | Double-Blind Method | Risk Assessment | Humans | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Disease Progression | Interferon-beta - therapeutic use | Young Adult | Magnetic Resonance Imaging | Interferon beta-1b | Adult | Female | Surveys and Questionnaires | Multiple Sclerosis - drug therapy | Clinical trials | Multiple sclerosis | Universities and colleges | Drug therapy | Biological response modifiers | Interferon beta | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text MRI in multiple sclerosis: current status and future prospects
by Bakshi, Rohit, MD and Thompson, Alan J, MD and Rocca, Maria A, MD and Pelletier, Daniel, MD and Dousset, Vincent, MD and Barkhof, Frederik, MD and Inglese, Matilde, MD and Guttmann, Charles RG, MD and Horsfield, Mark A, PhD and Filippi, Massimo, MD
Lancet neurology, ISSN 1474-4422, 2008, Volume 7, Issue 7, pp. 615 - 625
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Brain Mapping | Magnetic Resonance Imaging - methods | Magnetic Resonance Imaging - trends | Multiple Sclerosis - diagnosis | Humans | Medical colleges | Nuclear magnetic resonance spectroscopy | Multiple sclerosis | Magnetic resonance imaging | Metabolites | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights